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666a Wednesday, February 29, 2012shown that IgE plays a role in cell survival. Furthermore, the cytokinergic class
of IgEs can induce signaling in the absence of antigen-mediated crosslinking.
To examine IgE- and antigen-independent receptor behavior, we have gener-
ated a Fluorogen Activating Peptide (FAP)-tagged g-subunit that allows us
to track the non-IgE-bound receptor. Fluorogen activating peptides (FAPs)
are genetically expressible tags that increase the fluorescence excitation
cross-section of dye binding partners by up to four orders of magnitude, with
bound lifetimes of up to ten seconds. These properties make the FAP system
a convenient expressible probe for single particle tracking. We found that bind-
ing of non-cytokinergic IgE did not alter FcεRI mobility. However, in the pres-
ence of cytokinergic IgE (SPE7), we observed a decrease in mobility that is
dependent upon accessibility of the SPE7 variable region. The far red emission
of the malachite green based fluorogen (MG2p) is also advantageous for simul-
taneous tracking of FAP-g with respect to GFP-tagged proteins, such as cla-
thrin, to identify regions of receptor localization. To identify changes in
receptor distribution associated with binding of cytokinergic IgEs, we use
multi-colored direct STORM to simultaneously image the receptor bound to
cytokinergic and non-cytokinergic IgEs, and compare this to the receptor dis-
tribution in the absence of IgE.
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In mast cells, cross-linking of IgE bound to FcεR1 receptors with multivalent
antigen initiates cell activation and consequent inflammatory responses. Clus-
tered IgE-FcεRI interacts with early signaling partners such as Lyn, Syk, and
LAT, initiating a signaling cascade. Our previous scanning electron micros-
copy (SEM) studies quantified the nanoscale co-redistribution of FcεRI with
Lyn, Syk, and LAT within the plasma membrane upon antigen stimulation.
Here we use super-resolution localization microscopy to localize proteins on
the cell surface with sub-diffraction resolution using a TIR fluorescence micro-
scope. We present, in snapshots, the time-dependence of IgE receptor reorga-
nization after antigen addition using chemically fixed cells and quantify the
extent of clustering using pair autocorrelation functions. We have validated
our methods for quantifying and correcting for artifactual clustering due to
probe over-counting through two-color experiments where individual IgE pro-
teins are labeled with one of two species of distinguishable fluorescent probe
and imaged at sub-diffraction resolution in multiple color channels. Here clus-
tering is quantified using pair cross-correlation functions. Results of one- and
two-color super-resolution measurements agree well with conclusions from
SEM experiments. We have also extended this technique to imaging living cells
at room temperature to measure IgE receptor redistribution in real time. We
quantify the organization and diffusion behavior of proteins undergoing stim-
ulated responses with the excellent statistics afforded by the technique. Live
cell experiments are conducted under a variety of stimulation conditions,
such as in the presence of drugs that perturb membrane physical state or affect
actin cytoskeleton assembly. Our results confirm that super-resolution imaging
is an effective tool for quantitative imaging of cellular components at the nano-
scale. Our ongoing studies are providing new information to clarify the phys-
ical basis for spatial assembly of specific proteins in the plasma membrane
during early signaling events.
3383-Pos Board B244
Somatostatin and Neuropeptide-Y Differentially Inhibit Insulin Secretion
Tara A. Schwetz, David W. Piston.
Vanderbilt University, Nashville, TN, USA.
Glucose homeostasis is a tightly regulated process coordinated by insulin and
glucagon secretion. In b-cells, G-protein coupled receptor (GPCR) activation
facilitates the optimization of insulin secretion. Somatostatin (SST) and
Neuropeptide-Y (NPY) inhibit insulin secretion through Gi activation; this in-
hibitory effect is mediated by the SSTR2/5 and Y1 receptors, respectively.
Here, we questioned the mechanism by which SST and NPY attenuate insulin
secretion. Two-photon excitation microscopy was utilized to measure the com-
bined autofluorescence of NADH and NADPH (NAD(P)H, a cellular redox
state indicator) upon SST or NPY application. Treatment with SST or NPY in-
duces a supplementary increase in NAD(P)H autofluorescence at glucose levels
ranging from 5-23 mM compared to untreated control, suggesting that the in-
hibitory effect of SST and NPY is not mediated through metabolic inhibition.
We then tested the effect of these GPCR ligands on intracellular calcium
([Ca2þ]i). At glucose concentrations above ~7 mM, pancreatic islets display
synchronous oscillations in [Ca2þ]i, resulting in the pulsatile release of insulin.
SST treatment decreases the [Ca2þ]i oscillation frequency, while NPY has noeffect; the oscillation amplitude is not altered in the presence of either ligand.
Insulin secretion assays were performed at low (2.8 mM) and high (16.7 mM)
glucose levels to determine the effect of SST and NPY on the Gi pathway. At
both glucose concentrations, mSIRK, a Gbg-activating peptide, significantly
potentiates insulin secretion; treatment with mSIRK(L9A), which serves as
a negative control for mSIRK, does not affect secretion. However, combination
treatment with SST and mSIRK inhibits insulin secretion at high glucose com-
pared to mSIRK alone. Insulin secretion is not altered with NPY and mSIRK
treatment compared to mSIRK only. These data suggest that SST attenuates in-
sulin secretion through inhibition of Gbg acting on voltage-gated Ca2þ chan-
nels and/or phospholipase-C, while NPY inhibits insulin secretion through Ga.
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Fibroblast growth factor-21 (FGF21) is a newly appreciated endocrine ligand
that signals through fibroblast growth factor receptor-1 (FGFR1). Long term
FGF21 treatment has been shown to decrease blood glucose levels in diabetic
mouse models. Consequently, the signalling pathway of FGF21/FGFR1 has be-
come a target for the management of diabetes. FGF21 activity requires the ex-
pression of a unique co-receptor Klotho-beta (KLB). This dependence suggests
FGF21 signals through a FGFR1/KLB complex. To investigate the molecular
interactions between FGFR1 and KLB at the plasma membrane, we have cre-
ated fluorescently-labelled constructs of these receptors. Through FRAP, we re-
vealed that KLB has a significantly shorter recovery half-life than FGFR1.
After the addition of lactose, a competitive inhibitor of galectin lattice binding,
the recovery half-life of KLB increased with no effect on FGFR1. After addi-
tion of FGF21, cells co-expressing KLB and FGFR1 also showed increased re-
covery half-life. This suggests that KLB interacts with the galectin lattice and
co-expression of FGFR1 removes this interaction. To study complex formation
of FGFR1 and KLB with the addition of FGF21, we employed the recently de-
veloped technique of Number and Brightness Analysis. It was found that KLB
oligomerizes greater than 2-fold with the addition of FGF21; however, treat-
ment with lactose abolished this response. In contrast, FGFR1-expressing cells
showed no change in oligomerization state. In cells co-expressing KLB and
FGFR1, FGF21 induced no significant change in KLB aggregation state while
inducing a nearly 2-fold increase in FGFR1. Overall, these data suggest KLB
associates with the galectin lattice in the absence of FGFR1, and that FGFR1
and KLB form a 1:2 complex that transitions to 2:2 upon addition of FGF21.
Future studies will address how these interactions affect the downstream signal-
ling of this important endocrine factor.
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The importance of protein kinases in cell signaling and human disease is well
established. While much is understood about how these enzymes regulate the
cellular environment, the direct measurement of kinase activity in single intact
cells remains challenging. In the present work, a novel assay for measuring Epi-
dermal Growth Factor Receptor (EGFR) activity in single cells has been devel-
oped. EGFR is a receptor tyrosine kinase known to play a role in numerous
cancers and is implicated in the inflammatory response to air pollution. The
analysis of EGFR activity in clinical samples would provide valuable informa-
tion regarding mechanisms of disease and potential interventions, however
these samples tend to be small, heterogeneous mixtures of primary cells that
are difficult to analyze using existing technologies that require large cell pop-
ulations (e.g. Western blotting, flow cytometry) or expression of a genetically
encoded sensor (e.g. FRET). We have developed an assay for measuring the
phosphorylation dynamics within single intact cells using fluorescent substrate
peptides in conjunction with capillary electrophoresis (CE). A peptide reporter
is loaded into the cell of interest, phosphorylated by the intact cellular machin-
ery, and then the cell is lysed and its contents analyzed by CE using high sen-
sitivity laser-induced fluorescence detection. The ability to select individual
cells coupled with sensitivity to 1021 mol allows effective analysis of the clin-
ical samples we are interested in studying. This technology has been validated
using purified EGFR kinase domain and cell lysates, where the reporter is re-
sistant to degradation for at least 1 hour. Additionally, phosphorylation
(16.9% in 90 seconds) has been observed in an intact A431 cell treated with
the phosphatase inhibitor sodium pervanadate. Single cell studies are ongoing
